<rss version="2.0">
  <channel>
    <title>Biopharmaceuticals &amp; Biotherapeutics Press Releases from SmartBrief</title>
    <link>http://www.smartbrief.com/news/BIO/pressReleases.jsp?sb_code=RSS&amp;industry=Biopharmaceuticals%20%26%20Biotherapeutics</link>
    <description>Biopharmaceuticals &amp; Biotherapeutics Press Releases from SmartBrief</description>
    <item>
      <title>Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director</title>
      <link><![CDATA[http://www.smartbrief.com/news/BIO/industryPR-detail.jsp?id=62527D7D-0A84-4782-99F0-78ADF0482622&amp;sb_code=RSS&amp;i=Biopharmaceuticals%20%26%20Biotherapeutics]]></link>
      <description></description>
      <pubDate>Mon, 23 Nov 2009 05:34:31 CST</pubDate>
    </item>
    <item>
      <title>NUCRYST Announces Special Meeting of Shareholders</title>
      <link><![CDATA[http://www.smartbrief.com/news/BIO/industryPR-detail.jsp?id=FCC8576D-905C-4047-98EF-B46E2D2E078A&amp;sb_code=RSS&amp;i=Biopharmaceuticals%20%26%20Biotherapeutics]]></link>
      <description>PRINCETON, NJ, Nov. 20 /PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals Corp. announced today that a Special Meeting of Shareholders will be held on Monday, December 21, 2009. The purpose of the Meeting is to consider approval of two special resoluti...</description>
      <pubDate>Fri, 20 Nov 2009 17:34:31 CST</pubDate>
    </item>
    <item>
      <title>Reportlinker Adds Medical Specialty Bags - Global Market Trends</title>
      <link><![CDATA[http://www.smartbrief.com/news/BIO/industryPR-detail.jsp?id=76403381-DB54-472B-8F98-964EAB9B6A2B&amp;sb_code=RSS&amp;i=Biopharmaceuticals%20%26%20Biotherapeutics]]></link>
      <description></description>
      <pubDate>Fri, 20 Nov 2009 10:04:31 CST</pubDate>
    </item>
    <item>
      <title>European CHMP Formally Adopts Negative Opinion on Oncophage </title>
      <link><![CDATA[http://www.smartbrief.com/news/BIO/industryBW-detail.jsp?id=B1E1BDAB-C6A1-48EF-931D-87DFF7901760&amp;sb_code=RSS&amp;i=Biopharmaceuticals%20%26%20Biotherapeutics]]></link>
      <description>Antigenics Inc. (NASDAQ: AGEN) today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), has formally adopted a negative opinion on the marketing authorization ap...</description>
      <pubDate>Fri, 20 Nov 2009 07:34:31 CST</pubDate>
    </item>
    <item>
      <title>Dendreon Receives FDA Acknowledgement of Complete Response</title>
      <link><![CDATA[http://www.smartbrief.com/news/BIO/industryPR-detail.jsp?id=1915637C-8951-42D4-BDF3-213419748CE7&amp;sb_code=RSS&amp;i=Biopharmaceuticals%20%26%20Biotherapeutics]]></link>
      <description></description>
      <pubDate>Fri, 20 Nov 2009 07:34:31 CST</pubDate>
    </item>
    <item>
      <title>Genasense  Given as High-Dose IV Infusion with Chemotherapy Shows Promising Activity in Advanced Melanoma</title>
      <link><![CDATA[http://www.smartbrief.com/news/BIO/industryBW-detail.jsp?id=646D2909-2F41-4712-87E4-558A96482383&amp;sb_code=RSS&amp;i=Biopharmaceuticals%20%26%20Biotherapeutics]]></link>
      <description>Genta Incorporated (OTCBB: GETA.OB) announced preliminary results that show a high objective response rate in a pilot study of patients with advanced melanoma that incorporates the Company?s lead oncology product, Genasense® (oblimersen sodium) Injec...</description>
      <pubDate>Fri, 20 Nov 2009 07:34:31 CST</pubDate>
    </item>
  </channel>
</rss>
